tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
The FlyMidday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
4h ago
V
GM
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026
PremiumCompany Announcements
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026
9h ago
6K
KMDA
Kamada discontinues Phase 3 inhaled AAT clinical trial
PremiumThe Fly
Kamada discontinues Phase 3 inhaled AAT clinical trial
9h ago
KMDA
Kamada reiterates FY25 revenue guidance $178M-$182M
PremiumThe Fly
Kamada reiterates FY25 revenue guidance $178M-$182M
9h ago
KMDA
Kamada’s Growth Potential and Strategic Development Justify Buy Rating
PremiumRatings
Kamada’s Growth Potential and Strategic Development Justify Buy Rating
27d ago
KMDA
Kamada Ltd. Reports Strong Financial Growth in 2025
PremiumCompany AnnouncementsKamada Ltd. Reports Strong Financial Growth in 2025
28d ago
KMDA
Kamada Ltd. Reports Strong Growth Amid Challenges
Premium
Company Announcements
Kamada Ltd. Reports Strong Growth Amid Challenges
28d ago
KMDA
Kamada Ltd. Reports Strong Q3 2025 Financial Results with 30% Profit Growth
Premium
Company Announcements
Kamada Ltd. Reports Strong Q3 2025 Financial Results with 30% Profit Growth
28d ago
6K
KMDA
Kamada sees FY25 revenue $178M-$182M
PremiumThe Fly
Kamada sees FY25 revenue $178M-$182M
28d ago
KMDA
Kamada reports Q3 EPS 9c, consensus 9c
PremiumThe Fly
Kamada reports Q3 EPS 9c, consensus 9c
28d ago
KMDA
Kamada Ltd (KMDA) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Kamada Ltd (KMDA) Q3 Earnings Cheat Sheet
1M ago
KMDA
Kamada announces first patient enrolled into trial of CYTOGAM
PremiumThe Fly
Kamada announces first patient enrolled into trial of CYTOGAM
1M ago
KMDA
Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation
PremiumCompany AnnouncementsKamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation
1M ago
6K
KMDA
Kamada Ltd. Announces Annual General Meeting for December 2025
Premium
Company Announcements
Kamada Ltd. Announces Annual General Meeting for December 2025
2M ago
6K
KMDA
Kamada Ltd. Engages Investors at September Conferences
Premium
Company Announcements
Kamada Ltd. Engages Investors at September Conferences
3M ago
6K
KMDA
Kamada Ltd’s Earnings Call: Positive Growth and Strategic Initiatives
PremiumCompany Announcements
Kamada Ltd’s Earnings Call: Positive Growth and Strategic Initiatives
3M ago
KMDA
Kamada’s Strategic Growth and Financial Performance Drive Buy Rating
PremiumRatings
Kamada’s Strategic Growth and Financial Performance Drive Buy Rating
4M ago
KMDA
Kamada’s Strong Financial Performance and Growth Potential Justify Buy Rating
PremiumRatings
Kamada’s Strong Financial Performance and Growth Potential Justify Buy Rating
4M ago
KMDA
Kamada Ltd. Reports Strong 2025 Financial Growth
PremiumCompany Announcements
Kamada Ltd. Reports Strong 2025 Financial Growth
4M ago
KMDA
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025
PremiumCompany AnnouncementsKamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025
4M ago
6K
KMDA
Kamada reports Q2 EPS 13c, consensus 9c
Premium
The Fly
Kamada reports Q2 EPS 13c, consensus 9c
4M ago
KMDA
Kamada sees FY25 revenue $178M-$182M
Premium
The Fly
Kamada sees FY25 revenue $178M-$182M
4M ago
KMDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >